Introduction
Roseday-F 10 Tablet contains two lipid-lowering medicines. When lifestyle adjustments (e.g., a low-fat diet) have failed, it is used to lower the levels of lipids known as cholesterol and triglycerides in the blood. This medicine aids in the prevention of heart disease.
Roseday-F 10 Tablet can be taken with food. It can be taken at any time of day, however it is best if you take it at the same time every day. This will make it easier for you to remember to take it. Depending on your cholesterol levels and how you respond to this treatment, your doctor will prescribe the appropriate dose. Most individuals with high cholesterol and triglycerides don’t feel sick, but quitting your medicine can raise your lipid levels, worsening your health and raising your risk of heart disease and stroke.
Medicine Activity
Fenofibrate and Rosuvastatin are two lipid-lowering medicines found in Roseday-F 10 Tablet. Fenofibrate lowers triglyceride levels in the blood, but Rosuvastatin inhibits your body from producing “bad” cholesterol (LDL). Both increase the amount of “good” cholesterol in the body (HDL).
Uses
Roseday-F Tablet is used in treatment of High cholesterol
Prevention of Heart attack
Related Product
Roseday 5mg Tablet
Roseday 10mg Tablet
Roseday 20mg Tablet
Roseday 40 mg Tablet
Roseday A 10 Capsule
Roseday A 20mg Capsule
Roseday EZ 10mg Tablet
Roseday F 5mg Tablet
Roseday F 10 Tablet
Roseday F 20mg Tablet
Roseday Gold 10mg Capsule
Roseday Gold 20mg Capsule
Directions for use
Follow your doctor’s instructions on the dosage and duration of this medicine. Take it all in at once. It should not be chewed, crushed, or broken. Roseday-F 10 Tablet can be taken with food, however it is best if you take it at the same time every day.
Side effects
The majority of side effects are minor and will go away as your body adjusts to the medicine. If they don’t go away or you’re concerned about them, see your doctor.
Adverse effects of Roseday-F Tablet
Nausea
Headache
Abdominal pain
Muscle pain
Weakness
Reviews
There are no reviews yet.